Pharma giants warn of potential €100bn investment shift away from Europe
Major pharmaceutical companies have issued a stark warning to the European Commission that they may redirect up to €100 billion in planned European investments to the United States and other regions. According to a report in the Irish Times, a letter signed by several pharmaceutical heavyweights—including Ireland-based operations of Pfizer, Eli Lilly, and MSD (known … Read more
